Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-24-013642
Filing Date
2024-03-28
Accepted
2024-03-28 16:42:12
Documents
21

Document Format Files

Seq Description Document Type Size
1 424B3 gri-424b3prosuppno1tooffera.htm 424B3 2087614
2 business10a.jpg GRAPHIC 44408
3 business11a.jpg GRAPHIC 34482
4 business12a.jpg GRAPHIC 53120
5 business13a.jpg GRAPHIC 395414
6 business14a.jpg GRAPHIC 57447
7 business15a.jpg GRAPHIC 15021
8 business16a.jpg GRAPHIC 19551
9 business1a.jpg GRAPHIC 44628
10 business2a.jpg GRAPHIC 37056
11 business3a.jpg GRAPHIC 52730
12 business4a.jpg GRAPHIC 23524
13 business5a.jpg GRAPHIC 39590
14 business6a.jpg GRAPHIC 83695
15 business7a.jpg GRAPHIC 43990
16 business8a.jpg GRAPHIC 31742
17 business9a.jpg GRAPHIC 39199
18 image_0.jpg GRAPHIC 7155
19 image_1.jpg GRAPHIC 9557
20 image_2.jpg GRAPHIC 2343
21 logo.jpg GRAPHIC 111872
  Complete submission text file 0001628280-24-013642.txt   3666146
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-276205 | Film No.: 24799822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)